SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-008862
Filing Date
2024-01-31
Accepted
2024-01-31 16:56:01
Documents
1
Period of Report
2024-01-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm244773-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm244773-1_4seq1.xml 4 6222
  Complete submission text file 0001104659-24-008862.txt   7816
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARQULE, INC. 1 WALL STREET, 6TH FLOOR BURLINGTON MA 01803
Business Address
SCHWARTZ BRIAN (Reporting) CIK: 0001431322 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 24583723